Table 3.
Parameters | No PA/Con/Con | PA/Con/Con | No PA/HF/Con | PA/HF/Con | p Value Diet | p Value PA | p Value Interaction |
---|---|---|---|---|---|---|---|
Body weight (g) | 31.2±0.9 | 30.4±0.4 | 31.7±1.1 | 33.8±0.7 | 0.36 | 0.26 | 0.61 |
Tibial length (mm) | 19.67±0.63 | 20.00±0.79 | 20.33±0.86 | 20.08±0.5 | 0.41 | 0.23 | 0.57 |
Bone area (mm 2 ) | 4.67±0.12 | 4.73±0.19 | 4.19±0.18 a | 4.36±0.14 | 0.59 | 0.03 | 0.55 |
Trabecula area (mm 2 ) | 2.10±0.05 | 2.14±0.08 | 1.89±0.08 a | 1.96±0.06 | 0.01 | 0.46 | 0.75 |
Cortical area (mm 2 ) | 0.80±0.03 | 0.88±0.03 | 0.75±0.02 | 0.85±0.02 | 0.77 | 0.003 | 0.62 |
Cortical thickness (mm) | 0.11±0.005 | 0.12±0.007 | 0.11±0.005 | 0.12±0.003 | 0.77 | 0.049 | 0.91 |
Periosteal circumference (mm) | 7.65±0.10 | 7.69±0.15 | 7.23±0.16 a | 7.38±0.13 | 0.01 | 0.49 | 0.69 |
Endosteal circumference (mm) | 6.95±0.12 | 6.92±0.19 | 6.54±0.18 a | 6.58±0.16 a | 0.03 | 0.97 | 0.81 |
Total BMC (mg) | 2.12±0.04 | 2.20±0.05 | 1.87±0.06 a | 2.05±0.05 | 0.0006 | 0.01 | 0.31 |
Cortical BMC (mg) | 0.71±0.03 | 0.78±0.04 | 0.67±0.03 | 0.75±0.02 | 0.23 | 0.01 | 0.87 |
Trabecula BMC (mg) | 0.61±0.01 | 0.64±0.02 | 0.50±0.03 a | 0.49±0.03 a | 0.001 | 0.008 | 0.23 |
Total BMD (mg/mm 3 ) | 457.0±6.3 | 468.5±7.7 | 449.0±5.3 | 448.9±8.0 | 0.58 | 0.03 | 0.55 |
Cortical BMD (mg/mm 3 ) | 881.7±6.3 | 888.8±8.8 | 889.6±7.9 | 881.7±7.4 | 0.96 | 0.96 | 0.33 |
Trabecula BMD (mg/mm 3 ) | 286.9±4.0 | 300.3±6.2 | 261.6±5.0 a | 259.6±11.3 a | 0.08 | 0.002 | 0.10 |
Note. Data were expressed as mean ± SD (n = 6 per group). p Value was determined by analyzing the data using two‐way ANOVA with a HFD and early‐life PA as the main factors and their interactions. a p < 0.05 by t test compared with NoPA/Con/Con.
Abbreviations: Con, control; HFD, high‐fat diet; PA, physical activity.